TIDMDPH

RNS Number : 2964L

Dechra Pharmaceuticals PLC

09 September 2021

9 September 2021

Dechra Pharmaceuticals PLC

(the Company)

Notification of Transactions by Person Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 7 September 2021 Denise Goode, Non-Executive Director, purchased 136 ordinary shares in the Company.

Following this acquisition, Denise Goode's beneficial interest in the Company is 136 shares (0.0001% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Denise Goode 
     ------------------------------------  ---------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------------ 
 a)   Position/status                       Director 
     ------------------------------------  ---------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
     ------------------------------------------------------------------------ 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ---------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ---------------------------------- 
 b)   Nature of the                         Purchase of Shares 
       transaction 
     ------------------------------------  ---------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)          Volume(s) 
                                             GBP47.48          136 
     ------------------------------------  ----------------  ---------------- 
 d)        Aggregated information 
             *    Aggregate volume            136 
 
                                              GBP47.48 
             *    Price                       GBP6,457.28 
 
 
             *    Total 
     ------------------------------------  ---------------------------------- 
 e)   Date of the transaction               7 September 2021 
     ------------------------------------  ---------------------------------- 
 f)   Place of the transaction              London Stock Exchange 
     ------------------------------------  ----------------------------------

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBGGDCBSGDGBC

(END) Dow Jones Newswires

September 09, 2021 06:43 ET (10:43 GMT)

Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Dechra Pharmaceuticals
Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Dechra Pharmaceuticals